MeyersJD. Infections in marrow transplant recipients. In: MandellGL, DouglasRG, eds. Principles and practices of infectious disease. 3rd ed. New York: Churchill Livingstone, 1990:2291-4.
2.
RoweJM, CiobanuN, AscensaoJ, StadtmauerEA, WeinerRS, SchenkeinDP. Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. Ann Intern Med1994;120:143-58.
3.
VerfaillieC, WeisdorfD, HaakeR, HostetterM, RamsayNK, McGlaveP.Candida infections in bone marrow transplant recipients. Bone Marrow Transplant1991;8:177-84.
4.
GoodrichJM, ReedEC, MoriM, FisherLD, SkerrettS, DandlikerPS. Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. J Infect Dis1991;164:731-40.
5.
RouseySR, RusslerS, GottliebM, AshRC. Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation. Am J Med1991;91:484-92.
6.
DenningDW, StevensDA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis1990;12: 1147-201.
7.
GoodmanJL, WinstonDJ, GreenfieldRA, ChandrasekarPH, FoxB, KaizerH. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med1992;326:845-51.
8.
WingardJR, MerzWG, RinaldiMG, JohnsonTR, KarpJE, SaralR.Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med1991;325:1274-7.
9.
EllisME, ClinkH, ErnstP, HalimMA, PadmosA, SpenceD. Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis1994;13:3-11.
10.
PerfectJR, KlotmanME, GilbertCC, CrawfordDD, RosnerGL, WrightKA. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. J Infect Dis1992;165:891-7.
11.
O'donnellMR, SchmidtGM, TegtmeierBR, FaucettC, FaheyJL, ItoJ. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol1994;12:827-34.
12.
WingardJR. Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy. Clin Infect Dis1994;19(suppl 1):S49-53.
